In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers

NCT ID: NCT02647346

Last Updated: 2020-02-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

132 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the accuracy of a Smart Foot Mat for signals associated with diabetic foot ulcers in high-risk patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Foot Ulcer, Diabetic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participant cohort

Participants with diabetes that each have a history of healed Diabetic Foot Ulcer (DFU) prior to enrollment.

Group Type EXPERIMENTAL

Daily use of podimetrics smart-foot mat

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Daily use of podimetrics smart-foot mat

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male/Female, 18 years or older
* Diagnosis of type 1 or type 2 Diabetes Mellitus, controlled or uncontrolled
* Ankle Brachial Index (ABI) \>0.5
* Patient with history of previous foot ulcer.

Exclusion Criteria

* Active Charcot foot disease
* One or more plantar foot ulcers (UT Grade 1A-C, 2A-C \& 3A-C)
* Active Infection/Gangrene
* Active malignancy
* Immunosuppressive disease
* History of alcohol or drug abuse
* Pregnant women (verbal confirmation or confirmation obtained within current medical records)
* Cognitive deficit
* 2+ or great lower extremity edema
* End stage renal disease
* History of major lower extremity amputation (below knee or above knee amputation)
* Other issue that, at the discretion of the investigator, renders the subject ineligible for participation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Podimetrics, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Phoenix VA Health Care System

Phoenix, Arizona, United States

Site Status

University of Arizona

Tucson, Arizona, United States

Site Status

Center for Clinical Research Castro Valley

Castro Valley, California, United States

Site Status

Limb Preservation Platform

Fresno, California, United States

Site Status

VA Long Beach Health System

Long Beach, California, United States

Site Status

Miami VA Healthcare System

Miami, Florida, United States

Site Status

MetroWest Medical Center

Framingham, Massachusetts, United States

Site Status

Greenville Health System

Greenville, South Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Petersen BJ, Rothenberg GM, Lakhani PJ, Zhou M, Linders DR, Bloom JD, Wood KA, Armstrong DG. Ulcer metastasis? Anatomical locations of recurrence for patients in diabetic foot remission. J Foot Ankle Res. 2020 Jan 13;13:1. doi: 10.1186/s13047-020-0369-3. eCollection 2020.

Reference Type DERIVED
PMID: 31956341 (View on PubMed)

Frykberg RG, Gordon IL, Reyzelman AM, Cazzell SM, Fitzgerald RH, Rothenberg GM, Bloom JD, Petersen BJ, Linders DR, Nouvong A, Najafi B. Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers. Diabetes Care. 2017 Jul;40(7):973-980. doi: 10.2337/dc16-2294. Epub 2017 May 2.

Reference Type DERIVED
PMID: 28465454 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P-04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Orthotic Dose Response Study
NCT02629731 COMPLETED NA